TITLE

2008 - Review: Limited evidence suggests that statins are safe in patients with liver disease

AUTHOR(S)
Bates, Eric R.
PUB. DATE
August 2008
SOURCE
ACP Journal Club;8/19/2008, Vol. 149 Issue 2, p10
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a study regarding the use of statins in patients with liver disease and presents the author's views on it. It describes the procedure of the study, which revealed that statins are safe in patients with preexisting liver disease. The author argues that monitoring serum transaminase levels in the general population taking statins is not useful or cost-effective and that it might deprive many patients of the benefits of statin therapy.
ACCESSION #
34599504

 

Related Articles

  • COMMENTARY. Bates, Eric R. // Evidence Based Medicine;Oct2008, Vol. 13 Issue 5, p140 

    The article focuses on the statin therapy in patients with pre-existing liver disease. In notes that statins occasionally cause asymptomatic serum transaminase elevations. However, these elevations are resolved in 70% of cases with continued therapy or when therapy is discontinued without...

  • Atorvastatin/clopidogrel/diltiazem/prednisone interaction.  // Reactions Weekly;2/19/2011, Issue 1339, p9 

    The article describes the cases of two patients who were given atorvastatin in combination with clopidogrel and had elevated aminotransferase levels.

  • Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Henderson, Louise M.; Patel, Shital P.; Giordano, Thomas; Green, Linda; El-Serag, Hashem B.; Patel, Shital; Giordano, Thomas P // Digestive Diseases & Sciences;Jan2010, Vol. 55 Issue 1, p190 

    Background: We sought to determine the effect of statin therapy on serum AST and ALT levels in a cohort of HCV-infected veterans with well-characterized liver disease.Study: We examined liver biopsy records of consecutive HCV-infected patients and identified 20 patients...

  • The efficacy and cost-effectiveness of statins in low-risk patients. Gupta, Ajay K. // CMAJ: Canadian Medical Association Journal;11/8/2011, Vol. 183 Issue 16, p1821 

    An introduction to the journal is presented in which the editor discusses the efficacy and cost effectivenss of statins in low risk patients.

  • Optimise dosages and lower drug costs. Ahmed, Mohammed // GP: General Practitioner;1/21/2002, p62 

    Focuses on the improvement of the cost-effectiveness of drugs by dose optimization in Great Britain. Alterations in the strength of the medication to match the needed dose; Amount of savings from dose optimization of statins; Limitations of dose optimization for certain drugs.

  • Switch to ezetimibe/simvastatin proves worthwhile in the UK.  // PharmacoEconomics & Outcomes News;8/7/2010, Issue 609, p9 

    The article discusses research on the cost effectiveness of using ezetimibe/simvastatin compared with doubling statin doses for British patients with acute coronary syndromes, referencing a study by J. Reckless and colleagues published in the June 7, 2010 issue of "Value in Health."

  • How does cost effectiveness change over a product's life cycle?  // PharmacoEconomics & Outcomes News;6/11/2011, Issue 630, p12 

    The article discusses two research on the cost effectiveness atorvastatin and clopidogrel over the product life cycle, presented at the 16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.

  • Gitelman's syndrome presenting as intolerance to statin therapy. Freedman, Danielle B; Housley, David // Annals of Clinical Biochemistry;May2005, Vol. 42 Issue 3, p232 

    Several factors predisposing patients to statin-induced myopathy have been described. We describe a patient whose statin intolerance was associated with changes in serum potassium arising from previously undiagnosed Gitelman's syndrome.

  • Withholding statins in patients with underlying liver disease: wise or unwise? PERRILLO, ROBERT P. // Baylor University Medical Center Proceedings;Apr2010, Vol. 23 Issue 2, p113 

    In the article the author reflects on statin therapy in patients with underlying liver disease. Statin therapy is used to treat patients with hypercholesterolemia, and manufacturers recommend monitoring liver function during therapy. He reports that there is no relationship between chronic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics